Effect of sorafenib on murine liver rege
β
Caroline Hora; Pamela Romanque; Jean-FranΓ§ois F. Dufour
π
Article
π
2011
π
John Wiley and Sons
π
English
β 630 KB
Hepatocellular carcinoma (HCC) is a common cause of cancer-related death. Sorafenib prolongs survival of patients with advanced disease and is approved for the systemic treatment of unresectable HCC. It possesses antiangiogenic and antiproliferative properties by way of inhibition of the receptor ty